FAPI-PET for Tumor Detection

Recruiting Observational Study
Malignant Neoplasm
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
University Hospital, Essen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a prospective observational trial investigating correlation with histopathology, positive predictive value, detection rate, reproducibility and impact on clinical management of 68-Ga-FAPI PET/CT or PET/MRI in patients receiving this imaging modality for tumor staging or restaging as part of clinical care.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. FAPI-PET scheduled for staging or restaging as part of clinical routine for proven or suspected malignancy 2. Age ≥ 18 years. Exclusion Criteria: 1. Patient cannot give consent for the study 2. Patient can not lie flat or tolerate FAPI PET imaging 3. Unwillingness or inabil…
Contacts

Wolfgang Fendler, MD

+49 201 723 1862

wolfgang.fendler@uk-essen.de

CONTACT

Lukas Kessler, MD

+49 201 723 1862

lukas.kessler@uk-essen.de

CONTACT